Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 15/20 | 1.00 |
| ▸ | MMP2 | P08253 | 7/20 | 1.00 |
| ▸ | MMP13 | P45452 | 3/20 | 1.00 |
| ▸ | MMP14 | P50281 | 3/20 | 1.00 |
| ▸ | MMP9 | P14780 | 4/20 | 0.60 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3848826 | 1.00 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP14MMP9 | |
| SCHEMBL3848822 | 1.00 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP14MMP9 | |
| SCHEMBL3849438 | 0.93 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP14MMP9 | |
| SCHEMBL3849435 | 0.93 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP14MMP9 | |
| SCHEMBL3848351 | 0.91 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP14MMP9 | |
| SCHEMBL3850064 | 0.91 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP14MMP9 | |
| SCHEMBL3854084 | 0.91 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP14MMP9 | |
| SCHEMBL3852934 | 0.91 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP14MMP9 | |
| SCHEMBL3848672 | 0.91 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP14MMP9 | |
| SCHEMBL3847880 | 0.91 | ADAM17 (0.83) | ADAM17MMP2MMP13MMP14MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |